ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 62 filers reported holding ARBUTUS BIOPHARMA CORP in Q2 2019. The put-call ratio across all filers is 1.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $324,534 | +31.1% | 107,107 | +0.8% | 0.00% | +50.0% |
| Q4 2022 | $247,516 | +58.7% | 106,230 | +29.7% | 0.00% | +100.0% |
| Q3 2022 | $156,000 | -34.7% | 81,878 | -7.2% | 0.00% | -50.0% |
| Q2 2022 | $239,000 | -47.5% | 88,224 | -42.2% | 0.00% | -60.0% |
| Q1 2022 | $455,000 | -25.3% | 152,762 | -2.4% | 0.01% | -28.6% |
| Q4 2021 | $609,000 | +26.9% | 156,546 | +16.8% | 0.01% | +133.3% |
| Q1 2019 | $480,000 | -2.0% | 134,053 | +4.7% | 0.00% | -25.0% |
| Q4 2018 | $490,000 | – | 128,037 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COWEN AND COMPANY, LLC | 4,331,020 | $7,882,000 | 1.31% |
| RTW INVESTMENTS, LP | 6,869,281 | $12,502,000 | 0.35% |
| A.R.T. Advisors, LLC | 14,140 | $26,000 | 0.04% |
| Hudson Bay Capital Management LP | 975,000 | $1,774,000 | 0.03% |
| Secure Asset Management, LLC | 10,000 | $18,000 | 0.01% |
| OSAIC HOLDINGS, INC. | 1,774,935 | $3,230,000 | 0.01% |
| FNY Investment Advisers, LLC | 9,900 | $18,000 | 0.01% |
| Squarepoint Ops LLC | 322,225 | $586,000 | 0.01% |
| LMR Partners LLP | 107,912 | $196,000 | 0.01% |
| Virtu Financial LLC | 17,147 | $31,000 | 0.00% |